{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:17:34Z","timestamp":1790727454730,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R21EY035707"],"award-info":[{"award-number":["1R21EY035707"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["2P30EY001583"],"award-info":[{"award-number":["2P30EY001583"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010264","name":"Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ophtha.2025.01.022","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:47:18Z","timestamp":1738208838000},"page":"767-774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Twenty-Year Trends in Prevalence and Incidence of Diabetic Retinal Disease"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-118X","authenticated-orcid":false,"given":"Brian L.","family":"VanderBeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-0994","authenticated-orcid":false,"given":"Rebecca","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2025.01.022_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/fampra\/cmh417","article-title":"The impact of diabetic retinopathy: perspectives from patient focus groups","volume":"21","author":"Coyne","year":"2004","journal-title":"Fam Pract"},{"key":"10.1016\/j.ophtha.2025.01.022_bib3","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.01.022_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ophtha.2025.01.022_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/diacare.21.1.53","article-title":"Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado","volume":"21","author":"Tudor","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ophtha.2025.01.022_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2009.11.014","article-title":"Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study","volume":"149","author":"Varma","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archopht.122.4.552","article-title":"The prevalence of diabetic retinopathy among adults in the United States","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005\u20132008","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.01.022_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2025.01.022_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ophtha.2023.07.020","article-title":"Trends in the diagnosed prevalence and incidence of major eye diseases in Medicare Part B Fee-for-Service beneficiaries 68 years of age or older","volume":"130","author":"Ehrlich","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.01.022_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamaophthalmol.2022.0052","article-title":"Trends in prevalence and treatment of diabetic macular edema and vision-threatening diabetic retinopathy among Medicare Part B Fee-for-Service beneficiaries","volume":"140","author":"Lundeen","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/dc22-1834","article-title":"Trends in the prevalence and treatment of diabetic macular edema and vision-threatening diabetic retinopathy among commercially insured adults aged <65 years","volume":"46","author":"Lundeen","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ophtha.2025.01.022_bib13","doi-asserted-by":"crossref","first-page":"e074068","DOI":"10.1136\/bmj-2022-074068","article-title":"Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"381","author":"Shi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2025.01.022_bib14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/dc17-2524","article-title":"Changes in health insurance coverage under the Affordable Care Act: a national sample of U.S. adults with diabetes, 2009 and 2016","volume":"41","author":"Casagrande","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ophtha.2025.01.022_bib16","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","article-title":"Trends in diabetes treatment and control in U.S. adults, 1999\u20132018","volume":"384","author":"Fang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2025.01.022_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.01.022_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ajo.2013.06.035","article-title":"Identification of persons with incident ocular diseases using health care claims databases","volume":"156","author":"Stein","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archopht.126.7.986","article-title":"Identification of patients with diabetic macular edema from claims data: a validation study","volume":"126","author":"Bearelly","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamaophthalmol.2013.577","article-title":"Accuracy of International Classification of Diseases, Ninth Revision, Clinical Modification billing codes for common ophthalmic conditions","volume":"131","author":"Muir","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.oret.2020.08.004","article-title":"Effect of ICD-9 to ICD-10 transition on accuracy of codes for stage of diabetic retinopathy and related complications: results from the CODER Study","volume":"5","author":"Cai","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2025.01.022_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/1471-2458-13-318","article-title":"Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ophtha.2025.01.022_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ophtha.2010.12.033","article-title":"Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"118","author":"Elman","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.01.022_bib24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","article-title":"A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2","volume":"117","author":"Michaelides","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.01.022_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.ophtha.2025.01.022_bib26","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2025.01.022_bib27","doi-asserted-by":"crossref","first-page":"e0241767","DOI":"10.1371\/journal.pone.0241767","article-title":"Implementation and sustainment of a statewide telemedicine diabetic retinopathy screening network for federally designated safety-net clinics","volume":"15","author":"de Carvalho","year":"2020","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.ophtha.2025.01.022_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema","volume":"102","author":"Klein","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.01.022_bib29","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/dc19-1571","article-title":"The Affordable Care Act: effects of insurance on diabetes biomarkers","volume":"43","author":"Marino","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ophtha.2025.01.022_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2025.01.022_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2025.01.022_bib32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/dom.13172","article-title":"Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy","volume":"20","author":"Vilsb\u00f8ll","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ophtha.2025.01.022_bib33","first-page":"1","article-title":"Glucagon-like peptide-1 receptor agonists are not associated with an increased risk of progressing to vision-threatening diabetic retinopathy","volume":"10","author":"Tauqeer","year":"2024","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dom.13538","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review","volume":"21","author":"Bain","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ophtha.2025.01.022_bib35","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/IAE.0000000000002302","article-title":"Changes in diabetic retinopathy severity when treating diabetic macular edema with ranibizumab: DRCR.net protocol I 5-year report","volume":"38","author":"Bressler","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2025.01.022_bib36","first-page":"1098","article-title":"Update on the management of diabetic retinopathy: anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative retinopathy","volume":"13","author":"Bahr","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ophtha.2025.01.022_bib37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaophthalmol.2017.1595","article-title":"Accuracy of billing codes used in the therapeutic care of diabetic retinopathy","volume":"135","author":"Lau","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2296-12-91","article-title":"Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics","volume":"12","author":"Greiver","year":"2011","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.ophtha.2025.01.022_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamaophthalmol.2017.0089","article-title":"Ophthalmic screening patterns among youths with diabetes enrolled in a large US managed care network","volume":"135","author":"Wang","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.01.022_bib40","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.ophtha.2006.04.018","article-title":"Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study","volume":"113","author":"Paz","year":"2006","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:46:42Z","timestamp":1774417602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0161642025000764"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.01.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twenty-Year Trends in Prevalence and Incidence of Diabetic Retinal Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}